Establishing the 99
99th percentile
high sensitivity
myocardial infarction
reference values
troponin I
Journal
Biochemia medica
ISSN: 1846-7482
Titre abrégé: Biochem Med (Zagreb)
Pays: Croatia
ID NLM: 9610305
Informations de publication
Date de publication:
15 Jun 2019
15 Jun 2019
Historique:
received:
29
01
2019
accepted:
09
03
2019
entrez:
22
6
2019
pubmed:
22
6
2019
medline:
31
8
2019
Statut:
ppublish
Résumé
The knowledge of high sensitivity cardiac troponin I (hsTnI) distribution in a reference population is mandatory for its introduction in clinical practice. The aim of this study was to define the Upper Reference Limit (URL) of hsTnI measured by Single Molecule Counting technology (SMC) in an accurately selected reference population. In the study 1140 blood donors were included and selected on the basis of medical history and biomarkers. High sensitivity cardiac troponin I was measured by SMC technology (Clarity, Singulex, Alamed, USA). The 99th percentile was calculated by the non-parametric method according to the Clinical and Laboratory Standard Institute - CLSI C28-A3. The median age was 41 years (IQR: 28 - 50) and 69% were males. The overall 99th percentile was 5 ng/L (90% CI: 4.2 - 5.6). When considering sex-related differences, we found slight differences between the 99th percentile in males and females. Moreover, the 99th percentile trended with age, especially in females. We defined the 99th percentile of hs-cTnI measured by SMC technology in a highly selected healthy population, with only minor differences between males and females. Our findings provide the basic criteria for the reliable interpretation of hsTnI concentrations measured by the SMC technology in clinical settings.
Identifiants
pubmed: 31223265
doi: 10.11613/BM.2019.020901
pii: bm-29-2-020901
pmc: PMC6559611
doi:
Substances chimiques
Troponin I
0
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
020901Déclaration de conflit d'intérêts
Potential conflict of interest: None declared.
Références
Clin Chim Acta. 2018 Nov;486:224-231
pubmed: 30110608
Eur J Epidemiol. 2017 Jul;32(7):583-591
pubmed: 28585121
Clin Chem. 2018 Feb;64(2):398-399
pubmed: 29046331
Clin Chem. 2018 Apr;64(4):645-655
pubmed: 29343532
Eur Heart J Acute Cardiovasc Care. 2018 Mar;7(2):139-148
pubmed: 27574333
Clin Chem Lab Med. 2017 Nov 27;56(1):120-125
pubmed: 28586301
Clin Chem. 2017 Jan;63(1):261-263
pubmed: 27895086
Scand J Clin Lab Invest. 2017 Oct;77(6):428-432
pubmed: 28650717